10 mars 2015 : Theravectys. Delaware Court finds that Theravectys is reasonably likely to succeed on the merits of its tortious interference claim against Immune Design Corp. Cliquez ici pour en savoir plus

EVIAGENICS selected for PM’up regional grant

décembre 2014 : EVIAGENICS selected for PM’up regional grant. The purpose of this grant is to support the development of the Paris region SMB with high growth potential. The region selects projects with the greatest potential for value creation, employment, international development and sustainable development.